These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32484795)

  • 1. A replication-competent late liver stage-attenuated human malaria parasite.
    Goswami D; Betz W; Locham NK; Parthiban C; Brager C; Schäfer C; Camargo N; Nguyen T; Kennedy SY; Murphy SC; Vaughan AM; Kappe SH
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32484795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion.
    Goswami D; Patel H; Betz W; Armstrong J; Camargo N; Patil A; Chakravarty S; Murphy SC; Sim BKL; Vaughan AM; Hoffman SL; Kappe SH
    EMBO Mol Med; 2024 Apr; 16(4):723-754. PubMed ID: 38514791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice.
    Vaughan AM; Sack BK; Dankwa D; Minkah N; Nguyen T; Cardamone H; Kappe SHI
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29440367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Liver-Stage Biology of Malaria Parasites: Insights to Enable and Accelerate the Development of a Highly Efficacious Vaccine.
    Mo AX; McGugan G
    Am J Trop Med Hyg; 2018 Oct; 99(4):827-832. PubMed ID: 30141395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites.
    Butler NS; Schmidt NW; Vaughan AM; Aly AS; Kappe SH; Harty JT
    Cell Host Microbe; 2011 Jun; 9(6):451-62. PubMed ID: 21669394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.
    Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF
    BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporozoite immunization: innovative translational science to support the fight against malaria.
    Richie TL; Church LWP; Murshedkar T; Billingsley PF; James ER; Chen MC; Abebe Y; Natasha Kc ; Chakravarty S; Dolberg D; Healy SA; Diawara H; Sissoko MS; Sagara I; Cook DM; Epstein JE; Mordmüller B; Kapulu M; Kreidenweiss A; Franke-Fayard B; Agnandji ST; López Mikue MA; McCall MBB; Steinhardt L; Oneko M; Olotu A; Vaughan AM; Kublin JG; Murphy SC; Jongo S; Tanner M; Sirima SB; Laurens MB; Daubenberger C; Silva JC; Lyke KE; Janse CJ; Roestenberg M; Sauerwein RW; Abdulla S; Dicko A; Kappe SHI; Sim BKL; Duffy PE; Kremsner PG; Hoffman SL
    Expert Rev Vaccines; 2023; 22(1):964-1007. PubMed ID: 37571809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental vaccination by single dose sporozoite injection of blood-stage attenuated malaria parasites.
    Sattler JM; Keiber L; Abdelrahim A; Zheng X; Jäcklin M; Zechel L; Moreau CA; Steinbrück S; Fischer M; Janse CJ; Hoffmann A; Hentzschel F; Frischknecht F
    EMBO Mol Med; 2024 Sep; 16(9):2060-2079. PubMed ID: 39103697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites.
    van Schaijk BC; Ploemen IH; Annoura T; Vos MW; Foquet L; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Sajid M; Franetich JF; Lorthiois A; Leroux-Roels G; Meuleman P; Hermsen CC; Mazier D; Hoffman SL; Janse CJ; Khan SM; Sauerwein RW
    Elife; 2014 Nov; 3():. PubMed ID: 25407681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetically engineered
    Murphy SC; Vaughan AM; Kublin JG; Fishbauger M; Seilie AM; Cruz KP; Mankowski T; Firat M; Magee S; Betz W; Kain H; Camargo N; Haile MT; Armstrong J; Fritzen E; Hertoghs N; Kumar S; Sather DN; Pinder LF; Deye GA; Galbiati S; Geber C; Butts J; Jackson LA; Kappe SHI
    Sci Transl Med; 2022 Aug; 14(659):eabn9709. PubMed ID: 36001680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects.
    Kublin JG; Mikolajczak SA; Sack BK; Fishbaugher ME; Seilie A; Shelton L; VonGoedert T; Firat M; Magee S; Fritzen E; Betz W; Kain HS; Dankwa DA; Steel RW; Vaughan AM; Noah Sather D; Murphy SC; Kappe SH
    Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Development of Whole Sporozoite Vaccines for
    Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK
    Front Immunol; 2018; 9():2748. PubMed ID: 30619241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine.
    Kreutzfeld O; Müller K; Matuschewski K
    Front Cell Infect Microbiol; 2017; 7():198. PubMed ID: 28620583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
    Mueller AK; Labaied M; Kappe SH; Matuschewski K
    Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to whole sporozoite vaccination against malaria.
    Bijker EM; Borrmann S; Kappe SH; Mordmüller B; Sack BK; Khan SM
    Vaccine; 2015 Dec; 33(52):7462-8. PubMed ID: 26469716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
    Spring M; Murphy J; Nielsen R; Dowler M; Bennett JW; Zarling S; Williams J; de la Vega P; Ware L; Komisar J; Polhemus M; Richie TL; Epstein J; Tamminga C; Chuang I; Richie N; O'Neil M; Heppner DG; Healer J; O'Neill M; Smithers H; Finney OC; Mikolajczak SA; Wang R; Cowman A; Ockenhouse C; Krzych U; Kappe SH
    Vaccine; 2013 Oct; 31(43):4975-83. PubMed ID: 24029408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
    Labaied M; Harupa A; Dumpit RF; Coppens I; Mikolajczak SA; Kappe SH
    Infect Immun; 2007 Aug; 75(8):3758-68. PubMed ID: 17517871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.
    van Schaijk BC; Janse CJ; van Gemert GJ; van Dijk MR; Gego A; Franetich JF; van de Vegte-Bolmer M; Yalaoui S; Silvie O; Hoffman SL; Waters AP; Mazier D; Sauerwein RW; Khan SM
    PLoS One; 2008; 3(10):e3549. PubMed ID: 18958160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.